fbpx
November 30, 2021

Microbleeds, Age Contribute to ARIA Risk With Aducanumab Microbleeds, Age Contribute to ARIA Risk With Aducanumab

Though primary efficacy results have yet to be published, new safety findings from two large, randomized trials of aducanumab offer details on which patients are more […]
November 24, 2021

Coffee, Smoking and Aspirin Influence Parkinson’s Disease Onset Coffee, Smoking and Aspirin Influence Parkinson’s Disease Onset

Coffee drinking, aspirin use, and smoking influence the age of onset and the extent of clinical symptoms in patients with Parkinson’s disease (PD), early research suggests. […]
November 22, 2021

Post-TBI Cognitive Changes ‘Strikingly’ Similar to Early Parkinson’s Post-TBI Cognitive Changes ‘Strikingly’ Similar to Early Parkinson’s

Veterans who have sustained a mild traumatic brain injury (mTBI) show signs of premature cognitive decline that are comparable to those in patients with early Parkinson’s […]
November 19, 2021

Erenumab Bests Topiramate in First Head-to-Head Migraine Trial Erenumab Bests Topiramate in First Head-to-Head Migraine Trial

Erenumab, a calcitonin-gene related peptide receptor (CGRP) inhibitor, is more tolerable and effective than topiramate for treating patients with migraine, according to data from almost 800 […]
November 19, 2021

Largest Review on Clinical Features of Daily Persistent Headache Largest Review on Clinical Features of Daily Persistent Headache

Most cases of new daily persistent headache (NDPH) are moderate to severe and many feature characteristics often associated with migraine, according to a new retrospective chart review. […]
November 16, 2021

FDA Clears Virtual Reality System to Ease Chronic Back Pain FDA Clears Virtual Reality System to Ease Chronic Back Pain

The US Food and Drug Administration (FDA) has cleared EaseVRx (AppliedVR), an immersive virtual reality (VR) system that uses the principles of cognitive behavioral therapy and […]
November 16, 2021

Coffee or Tea? Drinking Both Tied to Lower Stroke, Dementia Risk Coffee or Tea? Drinking Both Tied to Lower Stroke, Dementia Risk

Drinking coffee or tea is associated with reduced risk for stroke and dementia, with the biggest benefit associated with consuming both beverages, new research suggests. Investigators […]
November 15, 2021

EMA Panel Backs Uplizna for Neuromyelitis Optica EMA Panel Backs Uplizna for Neuromyelitis Optica

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the immunosuppressant inebilizumab (Uplizna, Viela Bio) for […]
November 11, 2021

CNS Autoimmunity After COVID in Teens? CNS Autoimmunity After COVID in Teens?

Recent research suggests that some pediatric patients who develop neuropsychiatric symptoms from COVID-19 may have intrathecal antineural SARS-CoV-2 autoantibodies, which may hint at central nervous system […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0